Today's Information

Provided by: SYNMOSA BIOPHARMA CORPORATION
SEQ_NO 2 Date of announcement 2022/05/25 Time of announcement 18:20:28
Subject
 Announcement the re-election of Directors
(Including Independent Directors) of the Company
Date of events 2022/05/25 To which item it meets paragraph 6
Statement
1.Date of occurrence of the change:2022/05/25
2.Elected or changed position (Please enter institutional
director, institutional supervisor, independent director,
natural-person director or natural-person supervisor):
Institutional director、Independent director、Natural-person director
3.Title and name of the previous position holder:
Director-Lin, Chih-Hui
Director-Liao, Wan-Ru
Director-Representative of FORMOSA TIME PHARMACEUTICAL CO., LTD.: Zhang,
You-Peng
Director-Representative of FORMOSA TIME PHARMACEUTICAL CO., LTD.: Huang,
Li-Wen
Independent Director-Liu, Xiang-Lang
Independent Director-Fan, De-Quan
Independent Director-Lin, Xiu-Mei
4.Resume of the previous position holder:
Chairman of Synmosa Biopharma Corporation
Director of Synmosa Biopharma Corporation
Director of Synmosa Biopharma Corporation
Director of Synmosa Biopharma Corporation
Independent Director of Synmosa Biopharma Corporation
Independent Director of Synmosa Biopharma Corporation
Independent Director of Synmosa Biopharma Corporation
5.Title and name of the new position holder:
Director-Lin, Chih-Hui
Director-Chiu Hui-Lan
Director-Representative of FORMOSA TIME PHARMACEUTICAL CO., LTD.: Zhang,
You-Peng
Director-Representative of FORMOSA TIME PHARMACEUTICAL CO., LTD.: Huang,
Li-Wen
Independent Director-Liu, Xiang-Lang
Independent Director-Lin, Xiu-Mei
Independent Director-Wang Chien-Jen
6.Resume of the new position holder:
Chairman of Synmosa Biopharma Corporation
Director of Synmosa Biopharma Corporation
Director of Synmosa Biopharma Corporation
Director of Synmosa Biopharma Corporation
Independent Director of Synmosa Biopharma Corporation
Independent Director of Synmosa Biopharma Corporation
Independent Director of Synmosa Biopharma Corporation
7.Circumstances of change (Please enter "resignation", "dismissal",
"term expired", "death" or "new appointment"):term expired
8.Reason for the change:
Comprehensive re-election because term expired
9.Number of shares held by the new position holder when elected:
Director-Lin, Chih-Hui
Quantity of shareholding at the time of elected to office:12,498,685 shares
Director-Chiu Hui-Lan
Quantity of shareholding at the time of elected to office:71,484 shares
Director-Representative of FORMOSA TIME PHARMACEUTICAL CO., LTD.: Zhang,
You-Peng
Quantity of shareholding at the time of elected to office:21,445,664 shares
Director-Representative of FORMOSA TIME PHARMACEUTICAL CO., LTD.: Huang,
Li-Wen
Quantity of shareholding at the time of elected to office:21,445,664 shares
Independent Director-Liu, Xiang-Lang
Quantity of shareholding at the time of elected to office:0 shares
Independent Director-Lin, Xiu-Mei
Quantity of shareholding at the time of elected to office:3,214 shares
Independent Director-Wang Chien-Jen
Quantity of shareholding at the time of elected to office:1,265,000 shares
10.Original term (from __________ to __________):
from 2019/05/24~2022/05/23
11.Effective date of the new appointment:
from 2022/05/25~2025/05/24
12.Turnover rate of directors of the same term:25%
13.Turnover rate of independent directors of the same term:33%
14.Turnover rate of supervisors of the same term:NA
15.Change in one-third or more of directors (Please enter "Yes" or
"No"):No
16.Any other matters that need to be specified:None

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Synmosa Biopharma Corporation published this content on 25 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 May 2022 16:11:30 UTC.